Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection

Journal of Experimental Medicine

Volumn 215, Issue 7, 2018, Pages 1823-1838

  Huynh, Jeremy P ^a   Lin, Chih Chung ^a   Kimmey, Jacqueline M ^a   Jarjour, Nicholas N ^a   Schwarzkopf, Elizabeth A ^a   Bradstreet, Tara R ^a   Shchukina, Irina ^a   Shpynov, Oleg ^a,b   Weaver, Casey T ^c   Taneja, Reshma ^d   Artyomov, Maxim N ^a   Edelson, Brian T ^a   Stallings, Christina L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JetBrains   (Russian Federation)

^c University of Alabama at Birmingham   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BHLHE40 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; INTERLEUKIN 10; PROTEIN BINDING; REPRESSOR PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL; BIOLOGICAL MODEL; BONE MARROW CELL; C57BL MOUSE; DEFICIENCY; GENE LOCUS; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PATHOLOGY; TH1 CELL; TUBERCULOSIS;

ADAPTIVE IMMUNITY; ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; GENETIC LOCI; HOMEODOMAIN PROTEINS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-10; LYMPHOCYTES; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MYELOID CELLS; NEUTROPHILS; PROTEIN BINDING; REPRESSOR PROTEINS; TH1 CELLS; TUBERCULOSIS;

EID: 85054630864     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20171704     Document Type: Article

References (58)

1. Abram, C.L., G.L. Roberge, Y. Hu, and C.A. Lowell. 2014. Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice. J. Immunol. Methods. 408:89–100. https://doi.org/10.1016/j.jim.2014.05.009
2. h1-type immunity. J. Immunol. 183:718–731. https://doi.org/10.4049/jimmunol.0801212
3. Barber, D.L., K.D. Mayer-Barber, C.G. Feng, A.H. Sharpe, and A. Sher. 2011. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 186:1598–1607. https://doi.org/10.4049/jimmunol.1003304
4. Barnes, P.F., S. Lu, J.S. Abrams, E. Wang, M. Yamamura, and R.L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482–3489.
5. Beamer, G.L., D.K. Flaherty, B.D. Assogba, P. Stromberg, M. Gonzalez-Juarrero, R. de Waal Malefyt, B. Vesosky, and J. Turner. 2008. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J. Immunol. 181:5545–5550. https://doi.org/10.4049/jimmunol.181.8.5545
6. Berry, M.P.R., C.M. Graham, F.W. McNab, Z. Xu, S.A.A. Bloch, T. Oni, K.A. Wilkinson, R. Banchereau, J. Skinner, R.J. Wilkinson, et al. 2010. An interferon-inducibleneutrophil-drivenbloodtranscriptionalsignature in human tuberculosis. Nature. 466:973–977. https://doi.org/10.1038/ nature09247
7. Bloom, C.I., C.M. Graham, M.P.R. Berry, F. Rozakeas, P.S. Redford, Y. Wang, Z. Xu, K.A. Wilkinson, R.J. Wilkinson, Y. Kendrick, et al. 2013. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS One. 8:e70630. https://doi.org/10.1371/journal.pone.0070630
8. Bonecini-Almeida, M.G., J.L. Ho, N. Boéchat, R.C. Huard, S. Chitale, H. Doo, J. Geng, L. Rego, L.C.O. Lazzarini, A.L. Kritski, et al. 2004. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor β (TGF-β) and analysis of TGF-β receptors I and II in active tuberculosis. Infect. Immun. 72:2628–2634. https://doi.org/10.1128/IAI.72.5.2628-2634.2004
9. Bustamante, J., S. Boisson-Dupuis, L. Abel, and J.L. Casanova. 2014. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin. Immunol. 26:454–470. https://doi.org/10.1016/j.smim.2014.09.008
10. Chou, C., D.J. Verbaro, E. Tonc, M. Holmgren, M. Cella, M. Colonna, D. Bhat-tacharya, and T. Egawa. 2016. The Transcription Factor AP4 Mediates Resolution of Chronic Viral Infection through Amplification of Germinal Center B Cell Responses. Immunity. 45:570–582. https://doi.org/10.1016/j.immuni.2016.07.023
11. Cooper, A.M., D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243–2247. https://doi.org/10.1084/jem.178.6.2243
12. Demangel, C., P. Bertolino, and W.J. Britton. 2002. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 32:994–1002. https://doi.org/10 .1002/1521-4141(200204)32:4%3C994::AID-IMMU994%3E3.0.CO;2-6
13. de Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209–1220. https://doi.org/10.1084/jem.174.5.1209
14. Feng, C.G., M.C. Kullberg, D. Jankovic, A.W. Cheever, P. Caspar, R.L. Coffman, and A. Sher. 2002. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis. Infect. Immun. 70:6672–6679. https://doi.org/10.1128/IAI.70.12.6672-6679.2002
15. Flynn, J.L., J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249–2254. https://doi.org/10.1084/jem.178.6.2249
16. Gabryšová, L., A. Howes, M. Saraiva, and A. O’Garra. 2014. The regulation of IL-10 expression. Curr. Top. Microbiol. Immunol. 380:157–190.
17. Gazzinelli, R.T., I.P. Oswald, S.L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1792–1796.
18. +) Macrophages and Dendritic Cells. Immunity. 42:1197–1211. https://doi.org/10.1016/j.immuni.2015.05.018
19. Heng, T.S.P., and M.W. Painter. Immunological Genome Project Consortium. 2008. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9:1091–1094. https://doi.org/10.1038/ ni1008-1091
20. Hölscher, C., R.A. Atkinson, B. Arendse, N. Brown, E. Myburgh, G. Alber, and F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167:6957–6966. https://doi.org/10.4049/jimmunol.167.12.6957
21. Hörber, S., D.G. Hildebrand, W.S. Lieb, S. Lorscheid, S. Hailfinger, K. Schul-ze-Osthoff, and F. Essmann. 2016. The atypical inhibitor of NF-κB, IκBζ, controls macrophage interleukin-10 expression. J. Biol. Chem. 291:12851–12861. https://doi.org/10.1074/jbc.M116.718825
22. Huard, R.C., S. Chitale, M. Leung, L.C.O. Lazzarini, H. Zhu, E. Shashkina, S. Laal, M.B. Conde, A.L. Kritski, J.T. Belisle, et al. 2003. The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infect. Immun. 71:6871–6883. https://doi.org/10.1128/IAI.71.12.6871-6883.2003
23. Iyer, S.S., and G. Cheng. 2012. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 32:23–63. https://doi.org/10.1615/CritRevImmunol.v32.i1.30
24. Jones, E.A., and R.A. Flavell. 2005. Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster. J. Immunol. 175:7437–7446. https://doi.org/10.4049/jimmunol.175.11.7437
25. Kang, X., H.-J. Kim, M. Ramirez, S. Salameh, and X. Ma. 2010. The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J. Immunol. 184:3718–3724. https://doi.org/10.4049/jimmunol.0903613
26. Kimmey, J.M., J.P. Huynh, L.A. Weiss, S. Park, A. Kambal, J. Debnath, H.W. Virgin, and C.L. Stallings. 2015. Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection. Nature. 528:565–569. https://doi.org/10.1038/nature16451
27. Kopf, M., C. Schneider, and S.P. Nobs. 2015. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16:36–44. https://doi.org/10.1038/ni.3052
28. H17 responses. Nat. Immunol. 12:231–238. https://doi.org/10.1038/ni.1990
29. Lin, C.-C., T.R. Bradstreet, E.A. Schwarzkopf, J. Sim, J.A. Carrero, C. Chou, L.E. Cook, T. Egawa, R. Taneja, T.L. Murphy, et al. 2014. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Nat. Commun. 5:3551. https://doi.org/10.1038/ncomms4551
30. Lin, C.-C., T.R. Bradstreet, E.A. Schwarzkopf, N.N. Jarjour, C. Chou, A.S. Archambault, J. Sim, B.H. Zinselmeyer, J.A. Carrero, G.F. Wu, et al. 2016. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J. Exp. Med. 213:251–271. https://doi .org/10.1084/jem.20150568
31. Machanick, P., and T.L. Bailey. 2011. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics. 27:1696–1697. https://doi.org/10.1093/bioinformatics/btr189
32. MacMicking, J.D., G.A. Taylor, and J.D. McKinney. 2003. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science. 302:654–659. https://doi.org/10.1126/science.1088063
33. Maertzdorf, J., M. Ota, D. Repsilber, H.J. Mollenkopf, J. Weiner, P.C. Hill, and S.H.E. Kaufmann. 2011. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One. 6:e26938. https://doi.org/10.1371/journal.pone.0026938
34. Martínez-Llordella, M., J.H. Esensten, S.L. Bailey-Bucktrout, R.H. Lipsky, A. Marini, J. Chen, M. Mughal, M.P. Mattson, D.D. Taub, and J.A. Bluestone. 2013. CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response. J. Exp. Med. 210:1603–1619. https://doi.org/10.1084/jem.20122387
35. Maynard, C.L., L.E. Harrington, K.M. Janowski, J.R. Oliver, C.L. Zindl, A.Y. Rudensky, and C.T. Weaver. 2007. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 8:931–941. https://doi.org/10.1038/ni1504
36. McLean, C.Y., D. Bristor, M. Hiller, S.L. Clarke, B.T. Schaar, C.B. Lowe, A.M. Wenger, and G. Bejerano. 2010. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28:495–501. https://doi.org/10.1038/nbt.1630
37. Moreira-Teixeira, L., P.S. Redford, E. Stavropoulos, N. Ghilardi, C.L. Maynard, C.T. Weaver, A.P. Freitas do Rosário, X. Wu, J. Langhorne, and A. O’Garra. 2017. T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection. J. Immunol. 199:613–623. https://doi.org/10.4049/jimmunol.1601340
38. Murray, P.J., L. Wang, C. Onufryk, R.I. Tepper, and R.A. Young. 1997. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158:315–321.
39. Nandi, B., and S.M. Behar. 2011. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J. Exp. Med. 208:2251–2262. https://doi.org/10.1084/jem.20110919
40. Olobo, J.O., M. Geletu, A. Demissie, T. Eguale, K. Hiwot, G. Aderaye, and S. Britton. 2001. Circulating TNF-α, TGF-β, and IL-10 in tuberculosis patients and healthy contacts. Scand. J. Immunol. 53:85–91. https://doi.org/10.1046/j.1365-3083.2001.00844.x
41. Ow, J.R., Y.H. Tan, Y. Jin, A.G. Bahirvani, and R. Taneja. 2014. Stra13 and Sharp-1, the non-grouchy regulators of development and disease. Curr. Top. Dev. Biol. 110:317–338. https://doi.org/10.1016/B978-0-12-405943-6.00009-9
42. Poon, G.F.T., Y. Dong, K.C. Marshall, A. Arif, C.M. Deeg, M. Dosanjh, and P. Johnson. 2015. Hyaluronan Binding Identifies a Functionally Distinct Alveolar Macrophage-like Population in Bone Marrow-Derived Dendritic Cell Cultures. J. Immunol. 195:632–642. https://doi.org/10.4049/jimmunol.1402506
43. Redford, P.S., A. Boonstra, S. Read, J. Pitt, C. Graham, E. Stavropoulos, G.J. Bancroft, and A. O’Garra. 2010. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 40:2200–2210. https://doi.org/10.1002/eji.201040433
44. Redford, P.S., P.J. Murray, and A. O’Garra. 2011. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4:261–270. https://doi.org/10.1038/mi.2011.7
45. Riemann, M., R. Endres, S. Liptay, K. Pfeffer, and R.M. Schmid. 2005. The IkappaB protein Bcl-3 negatively regulates transcription of the IL-10 gene in macrophages. J. Immunol. 175:3560–3568. https://doi.org/10.4049/jimmunol.175.6.3560
46. Roach, D.R., E. Martin, A.G. Bean, D.M. Rennick, H. Briscoe, and W.J. Britton. 2001. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand. J. Immunol. 54:163–170. https://doi.org/10.1046/j.1365-3083.2001.00952.x
47. Saraiva, M., and A. O’Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10:170–181. https://doi.org/10.1038/ nri2711
48. Schmidt, E.F., L. Kus, S. Gong, and N. Heintz. 2013. BAC transgenic mice and the GENSAT database of engineered mouse strains. Cold Spring Harb. Protoc. 2013:200–206. https://doi.org/10.1101/pdb.top073692
49. Schreiber, T., S. Ehlers, L. Heitmann, A. Rausch, J. Mages, P.J. Murray, R. Lang, and C. Hölscher. 2009. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 183:1301–1312. https://doi.org/10.4049/jimmunol.0803567
50. St-Pierre, B., G. Flock, E. Zacksenhaus, and S.E. Egan. 2002. Stra13 homodi-mers repress transcription through class B E-box elements. J. Biol. Chem. 277:46544–46551. https://doi.org/10.1074/jbc.M111652200
51. Sun, H., and R. Taneja. 2000. Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc. Natl. Acad. Sci. USA. 97:4058–4063. https://doi.org/10.1073/pnas.070526297
52. Sun, H., B. Lu, R.Q. Li, R.A. Flavell, and R. Taneja. 2001. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2:1040–1047. https://doi.org/10.1038/ni721
53. Turner,J.,M.Gonzalez-Juarrero,D.L.Ellis,R.J.Basaraba,A.Kipnis,I.M.Orme, and A.M. Cooper. 2002. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 169:6343–6351. https://doi.org/10.4049/jimmunol.169.11.6343
54. Verbon, A., N. Juffermans, S.J. Van Deventer, P. Speelman, H. Van Deutekom, and T. Van Der Poll. 1999. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 115:110–113. https://doi.org/10.1046/j.1365-2249.1999.00783.x
55. Villagra, A., F. Cheng, H.-W. Wang, I. Suarez, M. Glozak, M. Maurin, D. Nguyen, K.L. Wright, P.W. Atadja, K. Bhalla, et al. 2009. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat. Immunol. 10:92–100. https://doi.org/10.1038/ni.1673
56. Yamada, H., S. Mizuno, M. Reza-Gholizadeh, and I. Sugawara. 2001. Relative importance of NF-kappaB p50 in mycobacterial infection. Infect. Immun. 69:7100–7105. https://doi.org/10.1128/IAI.69.11.7100-7105.2001
57. Yee, C.S.K., Y. Yao, Q. Xu, B. McCarthy, D. Sun-Lin, M. Tone, H. Waldmann, and C.-H. Chang. 2005. Enhanced production of IL-10 by dendritic cells deficient in CIITA. J. Immunol. 174:1222–1229. https://doi.org/10.4049/jimmunol.174.3.1222
58. Zhang, Y., T. Liu, C.A. Meyer, J. Eeckhoute, D.S. Johnson, B.E. Bernstein, C. Nusbaum, R.M. Myers, M. Brown, W. Li, and X.S. Liu. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9:R137. https://doi.org/10.1186/gb-2008-9-9-r137